The US state of Kentucky is set to enact new legislation that aims to prevent residents from purchasing prescription drugs on-line without medical supervision. Internet pharmacies that supply drugs to Kentucky residents would have to show both national certification of pharmacy competence and evidence that the patient had visited a physician before the drugs were dispensed.
Another significant element of the new regulations is to require that pharmacies in Kentucky track ephedrine and pseudoephedrene purchases in collaboration with the state's law enforcement agencies. The two products are used by criminals to manufacture "crystal meth" a notoriously dangerous narcotic drug.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze